9.3. 2017 BioTurku®

Medicortex Finland Oy received an innovation grant

Medicortex Finland Oy received an innovation grant for the development of a rapid diagnostic test for Traumatic Brain Injury

Runar Bäckström foundation awarded an innovation grant of € 15,000 to Medicortex Finland Oy for Rapid Diagnostic Test for Traumatic Brain Injury.

The aim of the Runar Bäckström foundation is to encourage and support inventions that are beneficial to Finnish businesses and thereby strengthen their global competitiveness. In its 2017 call, the foundation granted a total sum €225,000 to 15 applicants. The foundation awards grants once a year.

Medicortex Finland Oy is a start-up pharmaceutical company dedicated to improving the diagnostics and treatment of Traumatic Brain Injury (TBI). The current focus is on the development of biomarker diagnostics to evaluate the extent and severity of traumatic brain injury and concussion. Medicortex was founded by Dr. Adrian Harel in 2014 in Turku, Finland, and operates as a privately owned company in PharmaCity.